Global /Japan /Industrials /Specialty Business Services /6190

PhoenixBio Co., Ltd.

6190

• TSE: 6190 • Delayed

438JPY 2.3%

2.73 USD

As of 13 June 2026, PhoenixBio Co., Ltd. has a market cap of $10.88M USD, ranking #40838 globally and #3882 in Japan. It ranks #9343 in the Industrials sector, and #1194 in the Specialty Business Services industry.

Global Rank

40838

Country Rank

3882

Sector Rank

9343

Industry Rank

1194

Key Stats

Market Cap

$10.88MUSD

1.74B JPY

Enterprise Value

$6.41MUSD

1.03B JPY

Revenue (TTM)

$9.98MUSD

1.6B JPY

EBITDA (TTM)

$681.28KUSD

109.25M JPY

Net Income (TTM)

-$1.28MUSD

-205.0M JPY

EBITDA Margin

6.8%

Profit Margin

-13%

PS Ratio

1.1

PB Ratio

1.1

EV/EBITDA

9.4

Company Profile

Country (HQ)

Japan

Sector

Industrials

Industry

Specialty Business Services

CEO

Takashi Shimada open_in_new

Employees

Founded

2002

Website

phoenixbio.co.jp open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.3%	-4.9%	-9.7%	-7.3%	-14%	-11%	32%	-25%	-31%

News

Markets

Exchange	Ticker	Price	Quotes
Tokyo Stock Exchange (TSE / TYO) MIC: XTKS PRIMARY	6190 株式会社フェニックスバイオ ISIN: JP3803010002 Shares Out.: Shares Outstanding: 4.07M¹ Shares Float: 1.624M² TV: TradingView: TSE: 6190 SA: Stock Analysis: TYO: 6190 YF: Yahoo Finance: 6190.T GF: Google Finance: TYO: 6190 BA: Barron's: 6190 MS: Morningstar: XTKS: 6190	438 JPY	TV: TradingView: TSE: 6190 SA: Stock Analysis: TYO: 6190 YF: Yahoo Finance: 6190.T GF: Google Finance: TYO: 6190 BA: Barron's: 6190 MS: Morningstar: XTKS: 6190

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.

Similar Companies

Industry: Specialty Business Services (Japan)

Name	Market Cap (USD) diff.	PE	Country
SECOM CO., LTD. TSE: 9735	$14.55B 2.33T JPY 134K%	22.1	Japan
PayPay Corp. NASDAQ: PAYP	$13.65B 125K%	17.5	Japan
Eisai Co., Ltd. TSE: 4523	$8.11B 1.3T JPY 74K%	30.4	Japan
Baycurrent, Inc. TSE: 6532	$4.97B 795.87B JPY 46K%	21.0	Japan
Alsok Co.,Ltd. TSE: 2331	$3.66B 585.61B JPY 34K%	17.4	Japan
Visional, Inc. TSE: 4194	$1.87B 300.04B JPY 17K%	17.3	Japan

Industry: Specialty Business Services (Global)

Name	Market Cap (USD) diff.	PE	Country
Shopify Inc. NASDAQ: SHOP	$158.14B 1M%	129.8	Canada
Verisure plc STO: VSURE	$132.68B 114.8B EUR 1M%	-	United Kingdom
Cintas Corp. NASDAQ: CTAS	$69.6B 639K%	36.8	United States
RELX PLC LSE: REL	$63.78B 47.6B GBP 586K%	23.9	United Kingdom
PayPal Holdings, Inc. NASDAQ: PYPL	$45.83B 421K%	9.4	United States
T Thomson Reuters Corp. NEO: TRI	$41.8B 56.91B CAD 384K%	-	Canada

chevron_leftBack